T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rivian
RIVN
|
+$18.7B |
| 2 |
Apple
AAPL
|
+$5.48B |
| 3 |
NVIDIA
NVDA
|
+$5.33B |
| 4 |
Tesla
TSLA
|
+$4.47B |
| 5 |
Microsoft
MSFT
|
+$2.15B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$4.26B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.3B |
| 3 |
Morgan Stanley
MS
|
+$2.82B |
| 4 |
Global Payments
GPN
|
+$2.43B |
| 5 |
PayPal
PYPL
|
+$2B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.4% |
| 2 | Healthcare | 16.1% |
| 3 | Consumer Discretionary | 15.8% |
| 4 | Communication Services | 12.38% |
| 5 | Financials | 10.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Jones Lang LaSalle
JLL
$17B
| $8.3M | ﹤0.01% |
30,813
-2,030
| -6% | -$524K |
|
|
MASI
1427
DELISTED
Masimo
MASI
| $8.25M | ﹤0.01% |
28,185
+232
| +0.8% | +$66.1K |
|
1428
Fidelity National Financial
FNF
$12.8B
| $8.23M | ﹤0.01% |
163,999
+6,495
| +4% | +$311K |
|
|
NEWR
1429
DELISTED
New Relic, Inc.
NEWR
| $8.2M | ﹤0.01% |
74,572
+48,299
| +184% | +$4.66M |
|
|
OHPAU
1430
DELISTED
Orion Acquisition Corp. Unit
OHPAU
| $8.18M | ﹤0.01% |
830,786
-763
| -0.1% | -$7.55K |
|
1431
Robinhood
HOOD
$89.3B
| $8.18M | ﹤0.01% |
460,353
-223,233
| -33% | -$6.87M |
|
1432
Ally Financial
ALLY
$13.6B
| $8.17M | ﹤0.01% |
171,524
-541,061
| -76% | -$26.8M |
|
1433
WillScot Mobile Mini Holdings
WSC
$4.17B
| $8.07M | ﹤0.01% |
197,622
-2,878
| -1% | -$106K |
|
1434
Orchestra BioMed
OBIO
$266M
| $7.99M | ﹤0.01% |
798,683
-9,082
| -1% | -$89.5K |
|
|
FRONU
1435
DELISTED
Frontier Acquisition Corp. Units
FRONU
| $7.97M | ﹤0.01% |
806,587
-8,340
| -1% | -$82.8K |
|
1436
Fiverr
FVRR
$311M
| $7.96M | ﹤0.01% |
+70,014
| New | +$10.9M |
|
1437
Bentley Systems
BSY
$10.8B
| $7.89M | ﹤0.01% |
163,240
-4,388
| -3% | -$237K |
|
1438
Sensata Technologies
ST
$6.72B
| $7.88M | ﹤0.01% |
127,760
+5,283
| +4% | +$308K |
|
1439
Barings BDC
BBDC
$987M
| $7.83M | ﹤0.01% |
710,852
+149,467
| +27% | +$1.65M |
|
|
DS
1440
DELISTED
Drive Shack Inc.
DS
| $7.76M | ﹤0.01% |
5,427,872
-168,119
| -3% | -$370K |
|
|
NUAN
1441
DELISTED
Nuance Communications, Inc.
NUAN
| $7.75M | ﹤0.01% |
140,181
-16,333
| -10% | -$901K |
|
1442
ZTO Express
ZTO
$17.6B
| $7.7M | ﹤0.01% |
272,713
+26,176
| +11% | +$781K |
|
1443
Envista
NVST
$4.61B
| $7.68M | ﹤0.01% |
170,528
-11,187
| -6% | -$460K |
|
1444
RB Global
RBA
$16B
| $7.59M | ﹤0.01% |
124,068
-34
| -0% | -$2.27K |
|
|
SQSP
1445
DELISTED
Squarespace, Inc.
SQSP
| $7.58M | ﹤0.01% |
257,112
+25,431
| +11% | +$922K |
|
1446
ChargePoint
CHPT
$166M
| $7.57M | ﹤0.01% |
19,870
-47,959
| -71% | -$21.3M |
|
1447
CVRx
CVRX
$78.3M
| $7.42M | ﹤0.01% |
606,508
-16,107
| -3% | -$234K |
|
1448
MoonLake Immunotherapeutics
MLTX
$1.47B
| $7.39M | ﹤0.01% |
746,862
-9,441
| -1% | -$93.8K |
|
1449
VICI Properties
VICI
$29B
| $7.3M | ﹤0.01% |
242,495
-341
| -0.1% | -$9.88K |
|
|
EUCRU
1450
DELISTED
Eucrates Biomedical Acquisition Corp. Unit
EUCRU
| $7.29M | ﹤0.01% |
730,864
| – | – |
|
Similar funds
T. Rowe Price Associates's Q4 2021 Portfolio in Review
As of Q4 2021, T. Rowe Price Associates held 3,121 positions worth $1.11T, up 4.6% from $1.06T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q4 2021 filing shows 186 new, 817 increased, 1,825 reduced and 148 closed positions. Its largest new stake was Rivian: 162,080,423 shares worth $16.1B. The largest sale was Visa, an estimated $4.26B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2021 buy was Rivian: 162,080,423 shares worth $16.1B.
- T. Rowe Price Associates added most to Apple in Q4 2021, an estimated $5.48B increase.
- T. Rowe Price Associates's biggest Q4 2021 reduction was Visa, cutting an estimated $4.26B.
- T. Rowe Price Associates fully exited Acceleron Pharma in Q4 2021, selling an estimated $923M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $1.11T portfolio in Q4 2021.
- T. Rowe Price Associates opened 186 new positions and closed 148 in Q4 2021.
- T. Rowe Price Associates's portfolio value rose 4.6% quarter-over-quarter to $1.11T.
Based on T. Rowe Price Associates's 13F filing for Q4 2021, filed 14 Feb 2022.